The cell cryopreservation market size was valued at $10.3 billion in 2022, and is projected to reach $76.6 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032. Cryopreservation involves the preservation of organelles, cells, tissues, or any other biological component by freezing them at very low temperatures (−80°C to −196°C) and suspending their cellular metabolism, which preserves the cells for an indefinite amount of time. At low temperatures, biological and chemical reactions in living cells are dramatically reduced. Thus, cryopreservation plays a vital role in maintaining the integrity and functionality of cells, which make it suitable for biological research workflows. When water within cells freezes, ice formation can cause a solute imbalance and damage the cellular structure. Thus, the proper usage of techniques and a freezing medium containing the right cryoprotectants and additives can help researchers to maximize the post-thaw viability of cells for cell culture.
The growth of the global cell cryopreservation market is majorly driven by Increase in infertility among women coupled with rise in number of egg freezing cycles. According to The Society for Assisted Reproductive Technology, it was reported that the egg freezing cycle Increased by 31% from 2020 to 2021 in the U.S. In addition, rise in presence of biobanks is anticipated to drive the growth of the cell cryopreservation market. Biobanking has gained prominence due to its crucial role in facilitating biomedical research, drug discovery, and personalized medicine. According to the Biobank Resource Center, as of 2023, there are 340 registered biobanks, Including both Canadian and international biobanks.
Moreover, according to the Journal of Biopreservation and Biobanking, in 2022, it was reported that the BBMRI directory listed 641 biobanks from 17 countries (as of February 12, 2021). With the advancement of biobanking technologies and the establishment of larger and more comprehensive biobanks, the demand for efficient and reliable cell cryopreservation methods has grown significantly. Furthermore, Increase in R&D activities in pharmaceutical and biotechnology industries, rise in government support for R&D activities, and Increase in prevalence of chronic diseases such as cancer and Parkinson’s propel the growth of the market.
According to Health Resource and Service Administration, in 2023, it was reported that the donor registry contains more than 9 million potential donors in the U.S. Furthermore, as per the National Library of Medicine, in 2022, it was reported that various preclinical research activities are conducted in embryonic stem cells for the treatment of wide range of disease such as retinal diseases, Parkinson’s disease, Huntington’s disease, spinal cord injury, myocardial infarction, and type 1 diabetes. In addition, the Government of India conducted stem cell research through various departments and institutions by supporting basic as well as clinical research through national funding agencies such as the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST).
Furthermore, according to Regulatory Affairs Professionals Society, in 2021, there were around 2,754 clinics engaged in providing stem cell therapies. Consequently, the growing demand for stem cell therapies acts as a significant driver of the cell cryopreservation market. In addition, surge in demand for personalized medicines is expected to act as a significant driver of the cell cryopreservation market. Cell-based therapies, such as immune cell-based immunotherapies and engineered cell therapies, are being explored as personalized treatment approaches. Cryopreservation enables long-term storage of patient-specific cells, Including immune cells, which can be used in the development of personalized therapies.
By preserving these cells, cryopreservation ensures their availability when needed for patient-specific treatments. As the interest in personalized medicine continues to grow, the demand for cell cryopreservation methods and storage facilities Increases simultaneously, thereby augmenting the growth of the global market. Furthermore, rise in infertility rates notably contributes toward the growth of the market. However, availability of alternative therapies for cell cryopreservation and high maintenance cost in storage procedure hinder the growth of the market.
The global cell cryopreservation market is segmented into type, application, end user, and region. On the basis of type, the market is bifurcated into cryopreservation media and equipment. The cryopreservation media segment is further sub segmented into ethylene glycol, dimethyl sulfoxide, glycerol, and others. The equipment segment is subsegmented into freezers, liquid nitrogen supply tanks, and others.
Depending on application, the market is classified into stem cells, oocytes cells, sperm cells, and others. By end user, it is segregated into pharmaceutical & biotechnology company, research institute, and others. Region wise, it is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). The major companies profiled in the report Include Merck Group KGaA, HiMedia Laboratories, Thermo Fisher Scientific Inc., Eppendorf Corporate, BioLife Solutions, Inc., Lonza, Sartorius AG, Creative Biolabs, Sartorius AG, and PromoCell GmbH.
The growth of the global cell cryopreservation market is majorly driven by Increase in infertility among women coupled with rise in number of egg freezing cycles. According to The Society for Assisted Reproductive Technology, it was reported that the egg freezing cycle Increased by 31% from 2020 to 2021 in the U.S. In addition, rise in presence of biobanks is anticipated to drive the growth of the cell cryopreservation market. Biobanking has gained prominence due to its crucial role in facilitating biomedical research, drug discovery, and personalized medicine. According to the Biobank Resource Center, as of 2023, there are 340 registered biobanks, Including both Canadian and international biobanks.
Moreover, according to the Journal of Biopreservation and Biobanking, in 2022, it was reported that the BBMRI directory listed 641 biobanks from 17 countries (as of February 12, 2021). With the advancement of biobanking technologies and the establishment of larger and more comprehensive biobanks, the demand for efficient and reliable cell cryopreservation methods has grown significantly. Furthermore, Increase in R&D activities in pharmaceutical and biotechnology industries, rise in government support for R&D activities, and Increase in prevalence of chronic diseases such as cancer and Parkinson’s propel the growth of the market.
According to Health Resource and Service Administration, in 2023, it was reported that the donor registry contains more than 9 million potential donors in the U.S. Furthermore, as per the National Library of Medicine, in 2022, it was reported that various preclinical research activities are conducted in embryonic stem cells for the treatment of wide range of disease such as retinal diseases, Parkinson’s disease, Huntington’s disease, spinal cord injury, myocardial infarction, and type 1 diabetes. In addition, the Government of India conducted stem cell research through various departments and institutions by supporting basic as well as clinical research through national funding agencies such as the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST).
Furthermore, according to Regulatory Affairs Professionals Society, in 2021, there were around 2,754 clinics engaged in providing stem cell therapies. Consequently, the growing demand for stem cell therapies acts as a significant driver of the cell cryopreservation market. In addition, surge in demand for personalized medicines is expected to act as a significant driver of the cell cryopreservation market. Cell-based therapies, such as immune cell-based immunotherapies and engineered cell therapies, are being explored as personalized treatment approaches. Cryopreservation enables long-term storage of patient-specific cells, Including immune cells, which can be used in the development of personalized therapies.
By preserving these cells, cryopreservation ensures their availability when needed for patient-specific treatments. As the interest in personalized medicine continues to grow, the demand for cell cryopreservation methods and storage facilities Increases simultaneously, thereby augmenting the growth of the global market. Furthermore, rise in infertility rates notably contributes toward the growth of the market. However, availability of alternative therapies for cell cryopreservation and high maintenance cost in storage procedure hinder the growth of the market.
The global cell cryopreservation market is segmented into type, application, end user, and region. On the basis of type, the market is bifurcated into cryopreservation media and equipment. The cryopreservation media segment is further sub segmented into ethylene glycol, dimethyl sulfoxide, glycerol, and others. The equipment segment is subsegmented into freezers, liquid nitrogen supply tanks, and others.
Depending on application, the market is classified into stem cells, oocytes cells, sperm cells, and others. By end user, it is segregated into pharmaceutical & biotechnology company, research institute, and others. Region wise, it is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). The major companies profiled in the report Include Merck Group KGaA, HiMedia Laboratories, Thermo Fisher Scientific Inc., Eppendorf Corporate, BioLife Solutions, Inc., Lonza, Sartorius AG, Creative Biolabs, Sartorius AG, and PromoCell GmbH.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell cryopreservation market analysis from 2021 to 2031 to identify the prevailing cell cryopreservation market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cell cryopreservation market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report Includes the analysis of the regional as well as global cell cryopreservation market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Cryopreservation media
- Agent
- Ethylene glycol
- Dimethyl sulfoxide
- Glycerol
- Others
- Equipment
- Type
- Freezers
- Liquid nitrogen supply tanks
- Others
By Application
- Stem cells
- Oocytes cells
- Sperm cells
- Others
By End User
- Pharmaceutical and biotechnology company
- Research institute
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Malaysia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- BioLife Solutions, Inc.
- Creative Biolabs
- Danaher Corporation
- Eppendorf Corporate
- HiMedia Laboratories
- Lonza
- Merck Group KGaA
- PromoCell GmbH
- Sartorius AG
- Thermo Fisher Scientific Inc.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CELL CRYOPRESERVATION MARKET, BY TYPE
CHAPTER 5: CELL CRYOPRESERVATION MARKET, BY APPLICATION
CHAPTER 6: CELL CRYOPRESERVATION MARKET, BY END USER
CHAPTER 7: CELL CRYOPRESERVATION MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to a new report, titled, 'Cell Cryopreservation Market,' The cell cryopreservation market was valued at $10.3 billion in 2022, and is estimated to reach $76.6 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032. Cell cryopreservation is the process of freezing and storing cells at ultra-low temperatures to preserve their viability and functionality for extended periods. This technique allows cells to be stored and later thawed for use in research, medical treatments, or other applications. The applications covered in t study include stem cells, oocytes cells, sperm cells, and others. In addition, pharmaceutical & biotechnology company, research institute, and others are the major end users detailed in the report.Key factors driving the growth of the cell cryopreservation market due to rise in the number of biobanks, surge in demand for personalized medicines, and increase in R&D activities for stem cells. Rise in the number of biobanks acts as the key driving force of the cell cryopreservation market. This is attributed to the fact that biobank plays a crucial role in preservation and storage of biological samples, including cells and tissues for future research and clinical applications. The repository of biological materials has become increasingly important in various fields such as genomics personalized medicine and regenerative therapies. As of 2023, Global Biobank Meta-analysis Initiative collaborated with 24 different biobanks and have data of more than 2.2 million genotype.
Moreover, according to the Biobank Resource Centre, as of 2023, there are 340 registered biobanks globally. As the demand for high-quality and well-preserved biological sample continues to grow, the need for reliable cryopreservation techniques has intensified. In addition, surge in demand for stem cell therapies has seen a significant growth in recent years, emerging as major driver for the cell cryopreservation market. Stem cell therapy has shown promising results in the treatment of diseases such as cancer, autoimmune disorders, cardiovascular diseases, and neurological disorders. According to Regulatory Affairs Professionals Society, in 2021, there were around 2,754 clinics engaged in providing stem cell therapies. In 2016, only 570 clinics were engaged in stem cell therapy. This shows around 87.25% rise in the clinics providing stem cell therapy from 2016 to 2021. In addition, according to EuroStemCell, the most well-established and widely used stem cell treatment is the transplantation of blood stem cells. For instance, in 2021, Lifecell, the India's first and largest stem cell bank, reported that around 50,000 transplants have been done using stem cells across the globe.
In addition, increase in number of egg freezing cycles has played a significant role in driving the cell cryopreservation market. For instance, in 2021, Lifecell, the India's first and largest stem cell bank, reported that around 50,000 transplants have been done using stem cells across the globe. As per the same source, it was reported that 24,558 number egg freezing cycle were conducted in 2021. The cryopreserved oocyte is used in women having cancer, who want to have children. According to Center for Disease Control and Prevention (CDC), in 2021, it was reported that around 10% of women between the age of 15 years to 44 years are having difficulty in getting pregnant or staying pregnant, in the U.S.
The market also offers growth opportunities to the key players in the market. Government organizations are in support of research programs for various fatal disease such as cancer. For instance, in May 2022, the American Institute for Cancer Research funded more than $110 million for cancer research through its own grant program. Moreover, in 2021-22, it partnered with other leading cancer and biomedical research organizations to request $46.4 billion for National Institute of Health (NIH) in fiscal year (FY) 2022.
Similarly, in 2022, the Biden Administration established the Advanced Research Projects Agency for Health (ARPA-H). This new agency is tasked with focusing on high-risk, high-reward, and translational research.
The cell cryopreservation market is segmented into type, application, end user, and region. On the basis of type, the market is classified into cryopreservation media and equipment. The cryopreservation media segment is further sub segmented into ethylene glycol, dimethyl sulfoxide, glycerol, and others.. The equipment segment is sub segmented into freezers, liquid nitrogen supply tanks, and others. On the basis of application, the market is categorized into stem cells, oocytes cells, sperm cells, and others. On the basis of End user, the market is categorized into pharmaceutical & biotechnology company, research institute, and others.
- Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (India, China, Australia, Japan, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include Merck Group KGaA, HiMedia Laboratories, Thermo Fisher Scientific Inc., Eppendorf Corporate, BioLife Solutions, Inc., Lonza, Sartorius AG, Creative Biolabs, Sartorius AG, and PromoCell GmbH.
Key Market Insights (Updated)
- By type, the cryopreservation media segment was the highest revenue contributor, whereas equipment is anticipated to grow at the highest CAGR of 22.9% during the forecast period
- By application, the others segment was the highest revenue contributor, whereas stem cells is anticipated to grow at the highest CAGR of 23.2% during the forecast period
- By end user, the others segment was the highest revenue contributor, whereas it is anticipated to grow at the highest CAGR of 22.8% during the forecast period
- Based on region, North America garnered the largest revenue share in 2022, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 23.3% during the forecast period
Companies Mentioned
- BioLife Solutions, Inc.
- Creative Biolabs
- Danaher Corporation
- Eppendorf Corporate
- HiMedia Laboratories
- Lonza
- Merck Group KGaA
- PromoCell GmbH
- Sartorius AG
- Thermo Fisher Scientific Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 266 |
| Published | June 2023 |
| Forecast Period | 2022 - 2032 |
| Estimated Market Value ( USD | $ 10.3 billion |
| Forecasted Market Value ( USD | $ 76.6 billion |
| Compound Annual Growth Rate | 22.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
